Clinical study of dendritic cell vaccine combined with transarterial embolization for patients with hepatocellular carcinoma
Not Applicable
- Conditions
- hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000012702
- Lead Sponsor
- Faculty of Medical Sciences, University of Fukui
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
1) Severe concurrent disease 2) HIV antibody and/or HTLV-1 antibody positive 3) No other malignancy 4) No splenectomy 5) No Allograft transplantation 6) No immunosuppressive treatment 7) No treatment for HCC within 4 weeks 8) Pregnant and lactating females 9) Inappropriate for entry onto this study in the judgment of the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method